Fundamental dimension Equity attribute | AATVPeer $0.0840.00% Cap $3.07MP/E -14.5x QuantScore32/100 | ADVLeader $30.28▼-0.20% Cap $402.6MP/E -1.4x QuantScore38/100 | BAOSPeer $0.1663▼-2.06% Cap $255.2KP/E -0.0x QuantScore27/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
23/100 |
82/100 |
45/100 |
Valuation Multiples, PEG & DCF upside | 50/100 | 37/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 48/100 | 22/100 | 40/100 |
Growth Revenue / earnings growth & margins | 7/100 | 16/100 | 25/100 |
Sentiment Analyst ratings, targets & revisions | — | 33/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -14.5x | -1.4x | -0.0x |
Forward P/E (next FY) | — | -4.7x | — |
EV / EBITDA (TTM) | 52.0x | 25.3x | -0.0x |
Price / Sales | 1.0x | 0.1x | 0.7x |
Price / Free Cash Flow | -5.4x | 5.8x | -0.1x |
PEG ratio | 0.04 | -0.41 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 5 / 9 | 2 / 9 |
Altman Z-Score | 2.01 (Grey) | -0.12 (Distress) | -7.12 (Distress) |
Total debt / equity | 0.00 | 3.84 | 0.11 |
Quick ratio | 4.8x | 1.8x | 2.6x |
Interest coverage | -84.5x | 0.5x | -247.8x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -74.7% | -0.7% | -8.8% |
Net income growth YoY | -175.2% | +30.3% | +55.3% |
Gross margin (TTM) | 34.8% | 9.1% | -136.0% |
Operating margin (FY) | -128.0% | 0.5% | -1310.3% |
FCF margin (FY) | -96.1% | 1.6% | -397.8% |
5. Trailing price performancePrice change over period |
1M return | -15.2% | -10.8% | -40.2% |
3M return | -21.6% | -16.9% | -85.8% |
6M return | -16.0% | -9.3% | -93.9% |
Year to date | -24.3% | +37.6% | -93.9% |
1Y return | -6.7% | -19.3% | -94.8% |
3Y return | -66.1% | -49.5% | -96.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.2643 +214.7% upside | $1.92 -93.6% premium | $-1.15 -791.4% premium |
Wall Street consensus target | — — | $34.00 +12.3% · range $34.00–$34.00 | — — |
Consensus stance | — | 33% Buy67% Hold0% Sell | — |